MENU
HIND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vyome Holdings (HIND) Ownership - Who owns Vyome Holdings?

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.3M
P/E Ratio
N/A
Total Cash
8.8M
Projected Growth
N/A
Total Debt
22.55K
Revenue
152.72K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.25
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
View a ticker or compare two or three
HIND
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details